Login / Signup

Ferric Carboxymaltose Improves the Quality of Life of Patients with Inflammatory Bowel Disease and Iron Deficiency without Anaemia.

Jose Maria HuguetXavier Cortés-RizoMarta Maia Bosca-WattsMargarita MuñozNuria MarotoMarisa IborraEsther HinojosaMaría CapillaCarmina AsencioCirilo AmorosJose María Paredes
Published in: Journal of clinical medicine (2022)
A single dose of FCM rapidly restored iron parameters and significantly improved patients' symptoms and HRQoL at 1 month after treatment.
Keyphrases
  • iron deficiency
  • patients with inflammatory bowel disease
  • end stage renal disease
  • ejection fraction
  • chronic kidney disease
  • newly diagnosed
  • prognostic factors
  • peritoneal dialysis
  • depressive symptoms